Aspartate 171 is the major primate-specific determinant of human growth hormone - Engineering porcine growth hormone to activate the human receptor

被引:45
作者
Behncken, SN [1 ]
Rowlinson, SW [1 ]
Rowland, JE [1 ]
ConwayCampbell, BL [1 ]
Monks, TA [1 ]
Waters, MJ [1 ]
机构
[1] UNIV QUEENSLAND,CTR MOL & CELLULAR BIOL,BRISBANE,QLD 4072,AUSTRALIA
关键词
D O I
10.1074/jbc.272.43.27077
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
It has been known for more than 4 decades that only primate growth hormones are effective in primate species, but it is only with the availability of the 2.8 A structure of the human growth hormone (hGH). hGH-binding protein (hGHBP)(2) complex that Souza and co-workers (Souza, S. C., Frick, G. P., Wang, X., Kopchick, J. J., Lobo, R. B., and Goodman, H. M. (1995) Proc. Natl. Acad. Sci. U. S. A. 92, 959-963) were able to provide evidence that Arg-43 on the primate receptor is responsible. Here we have examined systematically the interaction between Arg-43 (primate receptor) or Leu-43 (non-primate receptors) and their complementary hormone residues Asp-171 (primate GH) and His-170 (nonprimate hormones) in a four-way comparison involving exchanges of histidine and aspartate and exchanges of arginine and leucine. BAF/BO3 lines were created and characterized which stably expressed hGH receptor, R43L hGH receptor, rabbit GH receptor, and L43R rabbit GH receptor. These were examined for site 1 affinity, for the ability to bind intact cells, and for proliferative biopotency using hGH, D171H hGH, porcine GH, or H170D porcine GH. We find that the single interaction between Arg-43 and His-170/171 is sufficient to explain virtually all of the primate species specificity, and this is congruent with the crystal structure. Accordingly, for the first time we have been able to engineer a nonprimate hormone to bind to and activate the human GH receptor.
引用
收藏
页码:27077 / 27083
页数:7
相关论文
共 24 条
[11]   THE 1ST DISULFIDE LOOP OF THE RABBIT GROWTH-HORMONE RECEPTOR IS REQUIRED FOR BINDING TO THE HORMONE [J].
GOBIUS, KS ;
ROWLINSON, SW ;
BARNARD, R ;
MATTICK, JS ;
WATERS, MJ .
JOURNAL OF MOLECULAR ENDOCRINOLOGY, 1992, 9 (03) :213-220
[12]   REDUCED I-125 HGH BINDING BY SERUM OF DWARF PIGS BUT NOT BY SERUM OF DWARFED POODLES [J].
LAUTERIC, TJ ;
TRIVEDI, B ;
KAPADIA, M ;
DAUGHADAY, WH .
COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY A-PHYSIOLOGY, 1988, 91 (01) :15-19
[13]  
LAYTON MJ, 1994, J BIOL CHEM, V269, P29891
[14]  
NICOLL CS, 1986, ENDOCR REV, V7, P169, DOI 10.1210/edrv-7-2-169
[15]   Dimerization of the extracellular domain of the erythropoietin (EPO) receptor by EPO: One high-affinity and one low-affinity interaction [J].
Philo, JS ;
Aoki, KH ;
Arakawa, T ;
Narhi, LO ;
Wen, J .
BIOCHEMISTRY, 1996, 35 (05) :1681-1691
[16]   A GROWTH-HORMONE AGONIST PRODUCED BY TARGETED MUTAGENESIS AT BINDING-SITE-1 - EVIDENCE THAT SITE-1 REGULATES BIOACTIVITY [J].
ROWLINSON, SW ;
BARNARD, R ;
BASTIRAS, S ;
ROBINS, AJ ;
BRINKWORTH, R ;
WATERS, MJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (28) :16833-16839
[17]   EVIDENCE FOR INVOLVEMENT OF THE CARBOXY-TERMINUS OF HELIX-1 OF GROWTH-HORMONE IN RECEPTOR-BINDING - USE OF CHARGE REVERSAL MUTAGENESIS TO ACCOUNT FOR CALCIUM-DEPENDENCE OF BINDING AND FOR DESIGN OF HIGHER AFFINITY ANALOGS [J].
ROWLINSON, SW ;
BARNARD, R ;
BASTIRAS, S ;
ROBINS, AJ ;
SENN, C ;
WELLS, JRE ;
BRINKWORTH, R ;
WATERS, MJ .
BIOCHEMISTRY, 1994, 33 (39) :11724-11733
[18]  
ROZAKISADCOCK M, 1992, J BIOL CHEM, V267, P7428
[19]  
SHANAFELT AB, 1991, J BIOL CHEM, V266, P13804
[20]   A SINGLE ARGININE RESIDUE DETERMINES SPECIES-SPECIFICITY OF THE HUMAN GROWTH-HORMONE RECEPTOR [J].
SOUZA, SC ;
FRICK, GP ;
WANG, XZ ;
KOPCHICK, JJ ;
LOBO, RB ;
GOODMAN, HM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (04) :959-963